Medical - Care Facilities
Compare Stocks
2 / 10Stock Comparison
DVA vs UNH
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
DVA vs UNH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Care Facilities | Medical - Healthcare Plans |
| Market Cap | $12.79B | $333.37B |
| Revenue (TTM) | $13.84B | $449.71B |
| Net Income (TTM) | $781M | $12.04B |
| Gross Margin | 31.1% | 18.8% |
| Operating Margin | 15.0% | 4.2% |
| Forward P/E | 13.7x | 20.1x |
| Total Debt | $15.05B | $78.39B |
| Cash & Equiv. | $758M | $24.36B |
DVA vs UNH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| DaVita Inc. (DVA) | 100 | 239.5 | +139.5% |
| UnitedHealth Group … (UNH) | 100 | 120.5 | +20.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DVA vs UNH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DVA carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 3 yrs, beta 0.05
- Lower volatility, beta 0.05, current ratio 1.29x
- Beta 0.05, current ratio 1.29x
UNH is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 11.8%, EPS growth -14.7%, 3Y rev CAGR 11.4%
- 220.3% 10Y total return vs DVA's 156.1%
- 11.8% revenue growth vs DVA's 6.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.8% revenue growth vs DVA's 6.5% | |
| Value | Lower P/E (13.7x vs 20.1x) | |
| Quality / Margins | 5.6% margin vs UNH's 2.7% | |
| Stability / Safety | Beta 0.05 vs UNH's 0.59 | |
| Dividends | 2.4% yield; 25-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +35.9% vs UNH's -4.7% | |
| Efficiency (ROA) | 4.5% ROA vs UNH's 3.9%, ROIC 10.5% vs 9.2% |
DVA vs UNH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DVA vs UNH — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DVA leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 32.5x DVA's $13.8B. Profitability is closely matched — net margins range from 5.6% (DVA) to 2.7% (UNH). On growth, DVA holds the edge at +6.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $13.8B | $449.7B |
| EBITDAEarnings before interest/tax | $2.8B | $23.2B |
| Net IncomeAfter-tax profit | $781M | $12.0B |
| Free Cash FlowCash after capex | $1.5B | $19.7B |
| Gross MarginGross profit ÷ Revenue | +31.1% | +18.8% |
| Operating MarginEBIT ÷ Revenue | +15.0% | +4.2% |
| Net MarginNet income ÷ Revenue | +5.6% | +2.7% |
| FCF MarginFCF ÷ Revenue | +10.8% | +4.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.0% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +43.5% | +0.7% |
Valuation Metrics
DVA leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 20.4x trailing earnings, DVA trades at a 27% valuation discount to UNH's 27.8x P/E. On an enterprise value basis, DVA's 9.9x EV/EBITDA is more attractive than UNH's 16.6x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $12.8B | $333.4B |
| Enterprise ValueMkt cap + debt − cash | $27.1B | $387.4B |
| Trailing P/EPrice ÷ TTM EPS | 20.39x | 27.76x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.68x | 20.06x |
| PEG RatioP/E ÷ EPS growth rate | 2.46x | — |
| EV / EBITDAEnterprise value multiple | 9.93x | 16.61x |
| Price / SalesMarket cap ÷ Revenue | 0.94x | 0.74x |
| Price / BookPrice ÷ Book value/share | 14.74x | 3.29x |
| Price / FCFMarket cap ÷ FCF | 9.76x | 20.74x |
Profitability & Efficiency
DVA leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
DVA delivers a 59.1% return on equity — every $100 of shareholder capital generates $59 in annual profit, vs $12 for UNH. UNH carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to DVA's 12.99x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs DVA's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +59.1% | +11.5% |
| ROA (TTM)Return on assets | +4.5% | +3.9% |
| ROICReturn on invested capital | +10.5% | +9.2% |
| ROCEReturn on capital employed | +14.0% | +9.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 12.99x | 0.77x |
| Net DebtTotal debt minus cash | $14.3B | $54.0B |
| Cash & Equiv.Liquid assets | $758M | $24.4B |
| Total DebtShort + long-term debt | $15.0B | $78.4B |
| Interest CoverageEBIT ÷ Interest expense | 3.54x | 4.71x |
Total Returns (Dividends Reinvested)
DVA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DVA five years ago would be worth $15,598 today (with dividends reinvested), compared to $9,746 for UNH. Over the past 12 months, DVA leads with a +35.9% total return vs UNH's -4.7%. The 3-year compound annual growth rate (CAGR) favors DVA at 29.5% vs UNH's -7.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +69.3% | +9.8% |
| 1-Year ReturnPast 12 months | +35.9% | -4.7% |
| 3-Year ReturnCumulative with dividends | +117.3% | -20.4% |
| 5-Year ReturnCumulative with dividends | +56.0% | -2.5% |
| 10-Year ReturnCumulative with dividends | +156.1% | +220.3% |
| CAGR (3Y)Annualised 3-year return | +29.5% | -7.3% |
Risk & Volatility
DVA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
DVA is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DVA currently trades 99.9% from its 52-week high vs UNH's 90.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.05x | 0.59x |
| 52-Week HighHighest price in past year | $194.10 | $404.72 |
| 52-Week LowLowest price in past year | $101.00 | $234.60 |
| % of 52W HighCurrent price vs 52-week peak | +99.9% | +90.7% |
| RSI (14)Momentum oscillator 0–100 | 59.8 | 74.5 |
| Avg Volume (50D)Average daily shares traded | 781K | 8.1M |
Analyst Outlook
UNH leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates DVA as "Hold" and UNH as "Buy". Consensus price targets imply 4.9% upside for UNH (target: $385) vs -13.0% for DVA (target: $169). UNH is the only dividend payer here at 2.37% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $168.67 | $385.43 |
| # AnalystsCovering analysts | 23 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | +2.4% |
| Dividend StreakConsecutive years of raises | 3 | 25 |
| Dividend / ShareAnnual DPS | — | $8.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +14.0% | +1.7% |
DVA leads in 5 of 6 categories (Income & Cash Flow, Valuation Metrics). UNH leads in 1 (Analyst Outlook).
DVA vs UNH: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is DVA or UNH a better buy right now?
For growth investors, UnitedHealth Group Incorporated (UNH) is the stronger pick with 11.
8% revenue growth year-over-year, versus 6. 5% for DaVita Inc. (DVA). DaVita Inc. (DVA) offers the better valuation at 20. 4x trailing P/E (13. 7x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DVA or UNH?
On trailing P/E, DaVita Inc.
(DVA) is the cheapest at 20. 4x versus UnitedHealth Group Incorporated at 27. 8x. On forward P/E, DaVita Inc. is actually cheaper at 13. 7x.
03Which is the better long-term investment — DVA or UNH?
Over the past 5 years, DaVita Inc.
(DVA) delivered a total return of +56. 0%, compared to -2. 5% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: UNH returned +220. 3% versus DVA's +156. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DVA or UNH?
By beta (market sensitivity over 5 years), DaVita Inc.
(DVA) is the lower-risk stock at 0. 05β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately 1137% more volatile than DVA relative to the S&P 500. On balance sheet safety, UnitedHealth Group Incorporated (UNH) carries a lower debt/equity ratio of 77% versus 13% for DaVita Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DVA or UNH?
By revenue growth (latest reported year), UnitedHealth Group Incorporated (UNH) is pulling ahead at 11.
8% versus 6. 5% for DaVita Inc. (DVA). On earnings-per-share growth, the picture is similar: DaVita Inc. grew EPS -11. 4% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, UNH leads at 11. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DVA or UNH?
DaVita Inc.
(DVA) is the more profitable company, earning 5. 5% net margin versus 2. 7% for UnitedHealth Group Incorporated — meaning it keeps 5. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DVA leads at 14. 7% versus 4. 2% for UNH. At the gross margin level — before operating expenses — DVA leads at 27. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DVA or UNH more undervalued right now?
On forward earnings alone, DaVita Inc.
(DVA) trades at 13. 7x forward P/E versus 20. 1x for UnitedHealth Group Incorporated — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UNH: 4. 9% to $385. 43.
08Which pays a better dividend — DVA or UNH?
In this comparison, UNH (2.
4% yield) pays a dividend. DVA does not pay a meaningful dividend and should not be held primarily for income.
09Is DVA or UNH better for a retirement portfolio?
For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
59), 2. 4% yield, +220. 3% 10Y return). Both have compounded well over 10 years (UNH: +220. 3%, DVA: +156. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DVA and UNH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
UNH pays a dividend while DVA does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.